Skip to main content
← News & Insights

UKFOS Oxford 2026 | Pre-event editorial spotlight

The Longevity Economy: Investing in Healthcare, Biotechnology and Healthy Ageing

Wednesday, 25 November 2026 | 14:30–15:10 | Ballroom, The Randolph Hotel, Oxford.

By UKFOS Editorial
Private Markets Group Ltd

Rosemary Sinclair Dokos, Neetu Puranikmath, Dr Jed Lye, Richard G.A. Faragher and Mila Morris, participants in The Longevity Economy panel at UK Family Office Summit Oxford 2026

Partner: Instance Ltd

Scientific progress, changing demographics and innovation in healthcare are bringing new attention to the longevity economy.

At UKFOS Oxford 2026, a dedicated Main Stage panel will examine the opportunities and challenges associated with investing in healthcare, biotechnology, preventive medicine and healthy ageing. The session, The Longevity Economy: Investing in Healthcare, Biotech & Healthy Ageing, will bring together perspectives from family capital, life sciences, healthcare and investment.

Understanding the longevity investment landscape

Longevity encompasses a broad range of activities, from established healthcare services and medical technologies to emerging biotechnology and scientific research. These areas differ significantly in their development timelines, capital requirements, regulatory exposure and commercial maturity.

For long-term investors, understanding these differences is essential. The panel will examine how investors can distinguish established commercial opportunities from technologies and business models that remain at earlier stages of development.

The importance of scientific and commercial evidence

Healthcare investment requires careful consideration of clinical evidence, regulatory pathways, market demand and the practical challenges of bringing new technologies to market. Promising scientific developments do not automatically translate into successful businesses.

Oxfordshire’s life sciences ecosystem

Oxfordshire provides a relevant setting for this discussion through its universities, research institutions and wider innovation environment. The panel will consider what research and innovation clusters can tell investors about the development of healthcare businesses and the infrastructure needed to support them.

Meet the panel

Moderator: Rosemary Sinclair Dokos — NucleicAI.

Panellists: Neetu Puranikmath — Single Family Office; Dr Jed Lye — Instance Ltd; Richard G.A. Faragher — University of Brighton; Mila Morris — Nova Arc Health.

Session: The Longevity Economy: Investing in Healthcare, Biotech & Healthy Ageing. Session Partner: Instance Ltd.

UK Family Office Summit Oxford 2026 is fully booked. The next Oxford Summit takes place on 23–24 November 2027. Explore upcoming UKFOS events.

Session Partner

Instance Ltd logo

UKFOS Oxford 2027

Continue the Conversation in Oxford

Join family offices, global asset owners and institutional investors at The Randolph Hotel, Oxford, on 23–24 November 2027.

23–24 November 2027
The Randolph Hotel
Beaumont Street, Oxford OX1 2LN, United Kingdom

UK FAMILY OFFICE SUMMIT

Register Your Interest & Stay Informed

Receive updates about UK Family Office Summit Oxford 2027, future Summits, private roundtables, investment discussions and selected opportunities across our family office and private capital network.

We respect your privacy. Your details will not be published or shared in a public delegate directory.